MSI

Clinical trials for MSI explained in plain language.

Never miss a new study

Get alerted when new MSI trials appear

Sign up with your email to follow new studies for MSI, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

Immunotherapy combo tested as last hope for tough colon cancers

Disease control Terminated

This study tested whether combining two immunotherapy drugs (atezolizumab and bevacizumab) could shrink tumors in people with advanced colorectal cancer that had stopped responding to standard chemotherapy. The trial enrolled 46 adults whose cancer had a specific genetic signatur…

Matched conditions: MSI

Phase: PHASE2 • Sponsor: Vall d'Hebron Institute of Oncology • Aim: Disease control

Last updated Apr 01, 2026 14:43 UTC

MSI

Get alerted when new MSI trials appear

Immunotherapy combo tested as last hope for tough colon cancers